Eli Lilly Agrees To Pay $15M To Settle Alaska Medicaid Lawsuit Filed Over Zyprexa Allegations

Main Category: Pharma Industry / Biotech Industry
Also Included In: Litigation / Medical Malpractice;  Schizophrenia
Article Date: 27 Mar 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 and a half stars

3.5 (2 votes)

Healthcare Prof:not yet rated

Article Opinions: 1 posts

Eli Lilly has agreed to pay $15 million to settle a lawsuit filed by the state of Alaska over allegations that the company concealed data about the side effects of Zyprexa, a schizophrenia and bipolar disorder medication, and cost the state Medicaid program millions of dollars because of an increased incidence of diabetes among beneficiaries, the Indianapolis Star reports (Spalding, Indianapolis Star, 3/26). According to the lawsuit, filed in 2006, Zyprexa led to a number of health problems -- such as weight gain, hypertension and diabetes -- in Alaska Medicaid beneficiaries (AP/Miami Herald, 3/26). The lawsuit sought $270 million in damages.

Under the settlement, which ended a trial that began on March 3, Lilly agreed to ensure that Alaska is "treated as favorably as any other state" in any future settlements of similar lawsuits (Indianapolis Star, 3/26). Lilly faces lawsuits filed by at least nine other states over allegations that the company illegally marketed Zyprexa for unapproved uses and concealed data on the side effects of the medication (Manzor, Wall Street Journal, 3/26). Lilly made no admission of wrongdoing in the settlement (AP/Miami Herald, 3/26).

Lilly general counsel Robert Armitage said that the company had a "strong defense" but decided to settle the lawsuit in the interests of all parties involved. He added, "Our decision to resolve this case does not change the fact that Zyprexa can continue to improve the lives of patients around the world who are suffering from schizophrenia and bipolar disorder" (Indianapolis Star, 3/26).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Zyprexa.


Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Eli Lilly Agrees To Pay $15M To Settle Alaska Medicaid Lawsuit Filed Over Zyprexa Allegations." Medical News Today. MediLexicon, Intl., 27 Mar. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/101839.php>

APA
Kaiser. (2008, March 27). "Eli Lilly Agrees To Pay $15M To Settle Alaska Medicaid Lawsuit Filed Over Zyprexa Allegations." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/101839.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »